Oncology Diagnostics & Services
Cancer
DevelopmentActive
Key Facts
About Phase Scientific
Phase Scientific Americas is a Los Angeles-based, high-growth biotech company focused on the diagnostics sector, with a core emphasis on infectious diseases and cancer. The company's commercial portfolio centers on the INDICAID brand of over-the-counter (OTC) and point-of-care (POC) rapid antigen tests, and it is expanding its pipeline with novel technologies like the PHASiFY sample preparation platform and at-home collection kits. Founded by bioengineers, Phase Scientific leverages its academic roots to develop accessible diagnostic solutions aimed at reducing the global burden of disease through early detection and easier testing.
View full company profileTherapeutic Areas
Other Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| Not Specified (Oncology Focus) | Narwhal Bio | Pre-clinical |
| EDM Platform for Genetic Medicine | Coastar Therapeutics | Pre-clinical |
| CO-1 | Caedo Oncology | Pre-clinical |
| Anti-CD99 monoclonal antibody | Caedo Oncology | Discovery/Pre-clinical |
| Anti-HLA class I monoclonal antibody | Caedo Oncology | Discovery/Pre-clinical |
| Triapine® | Nanopharmaceutics | Clinical |
| Ammonium Tetrathiomolybdate | Nanopharmaceutics | Clinical |
| Aza-TdC | Nanopharmaceutics | Clinical |
| Undisclosed Oncology Program(s) | Cell BioEngines | Phase 1 |
| No-alpha IL-2 Mutein | SarcoMed USA | Pre-clinical |
| PMIS Therapeutic | NaturemiRI | Preclinical/Clinical (unspecified) |
| AUM302 (formerly IBL-302) | Inflection Biosciences | Pre-clinical (partnered) |